Mycenax

Mycenax Contract Manufacturing & Development (CDMO) Profile

Headquartered in Taipei, Taiwan, Mycenax is a biologics CDMO for mAbs, BsAb, ADCs, rProteins, Vaccines, Plasmid DNA, and Cell Therapy. We offer integrated services in Cell Line Development (CHO, Sp2/0, E. coli), Process Development, Formulation, CMC, Analytical Method Development , DS/DP GMP Manufacturing/Fill-Finish to support our clients in various drug stages from Pre-Clinical/Tox batch, IND-enabling, Clinical/Phase I to III, to Commercial. Here is our company website www.mycenaxbio.com

CDMO Services:
Biologics; Cell & Gene Therapy Blow-Fill-Seal (BFS); Cartridges; Liquids; Lyophilized amps/vials; Pre-Filled Syringes (PFS); Semi-solids; Sterile Ampoules; Sterile Vials Analytical Development; Cell Line Development; Drug Delivery System; Formulation Development; ICH Stability Testing; Process Development; Protein Synthesis Antibodies; Antibody-drug conjugate (ADC); Fusion Proteins; Recombinants + other Proteins; Protein Vaccines; Plasmid DNA; Live Biotherapeutic Products

Number of Facilities: 3-5

Facility locations: East Asia

Website: Visit the Mycenax website

Linkedin: Connect on Linkedin

Current Capacity: Capacity available;immediately within 1-3 months